Mesenchymal stem cells alleviate bacteria-induced liver injury in mice by inducing regulatory dendritic cells. 2014

Yi Zhang, and Wei Cai, and Qingrong Huang, and Yuting Gu, and Yufang Shi, and Jiefang Huang, and Fang Zhao, and Qiang Liu, and Xunbin Wei, and Min Jin, and Changping Wu, and Qing Xie, and Yi Zhang, and Bing Wan, and Yanyun Zhang
Shanghai Institute of Immunology, Institutes of Medical Sciences, Shanghai Jiao Tong University School of Medicine (SJTUSM) and Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences & SJTUSM, Shanghai, China.

Fulminant hepatic failure (FHF) is a clinical syndrome characterized by sudden and severe impairment of liver function. Mesenchymal stem cells (MSCs) have been proposed as a promising therapeutic approach for FHF. In this study we used Propionibacterium acnes (P. acnes)-primed, lipopolysaccharide (LPS)-induced liver injury in mice as an animal model of human FHF. We demonstrated that administration of MSCs significantly ameliorated liver injury and improved the survival rates of mice subjected to P. acnes plus LPS-induced FHF. Allogeneic MSCs showed similar treatment efficacy as autologous MSCs did in FHF. Treatment efficacy of MSCs could be attributed to decreased infiltration and activation of CD4(+) T cells in the liver, inhibition of T helper 1 cells, and induction of regulatory T cells (Tregs). Moreover, decreased DNA copies of P. acnes were detected in the liver of MSC-treated mice. Intriguingly, a distinct liver population of CD11c(+) MHCII(hi) CD80(lo) CD86(lo) regulatory dendritic cells (DCs) was induced by MSCs. Moreover, these DCs induced Treg differentiation through transforming growth factor-β production. Further mechanistic studies demonstrated that MSC-derived prostaglandin E2 and one of its receptors, EP4, played essential roles in the differentiation of CD11c(+) B220(-) DC precursors into regulatory DCs in a phosphoinositide 3-kinase-dependent manner. CONCLUSIONS MSCs induce regulatory DCs from CD11c(+) B220(-) DC precursors. This study elucidates an immunoregulatory mechanism of MSCs and lays a foundation for application of MSCs in FHF therapy.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D011425 Propionibacterium acnes A bacteria isolated from normal skin, intestinal contents, wounds, blood, pus, and soft tissue abscesses. It is a common contaminant of clinical specimens, presumably from the skin of patients or attendants. Corynebacterium acnes,Corynebacterium parvum
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D016212 Transforming Growth Factor beta A factor synthesized in a wide variety of tissues. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. TGF-beta is found mostly as homodimer forms of separate gene products TGF-beta1, TGF-beta2 or TGF-beta3. Heterodimers composed of TGF-beta1 and 2 (TGF-beta1.2) or of TGF-beta2 and 3 (TGF-beta2.3) have been isolated. The TGF-beta proteins are synthesized as precursor proteins. Bone-Derived Transforming Growth Factor,Platelet Transforming Growth Factor,TGF-beta,Milk Growth Factor,TGFbeta,Bone Derived Transforming Growth Factor,Factor, Milk Growth,Growth Factor, Milk
D016908 Gram-Positive Bacterial Infections Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method. Bacterial Infections, Gram-Positive,Infections, Gram-Positive Bacterial,Bacterial Infection, Gram-Positive,Bacterial Infections, Gram Positive,Gram Positive Bacterial Infections,Gram-Positive Bacterial Infection,Infection, Gram-Positive Bacterial,Infections, Gram Positive Bacterial

Related Publications

Yi Zhang, and Wei Cai, and Qingrong Huang, and Yuting Gu, and Yufang Shi, and Jiefang Huang, and Fang Zhao, and Qiang Liu, and Xunbin Wei, and Min Jin, and Changping Wu, and Qing Xie, and Yi Zhang, and Bing Wan, and Yanyun Zhang
August 2014, Experimental cell research,
Yi Zhang, and Wei Cai, and Qingrong Huang, and Yuting Gu, and Yufang Shi, and Jiefang Huang, and Fang Zhao, and Qiang Liu, and Xunbin Wei, and Min Jin, and Changping Wu, and Qing Xie, and Yi Zhang, and Bing Wan, and Yanyun Zhang
November 2018, Gut and liver,
Yi Zhang, and Wei Cai, and Qingrong Huang, and Yuting Gu, and Yufang Shi, and Jiefang Huang, and Fang Zhao, and Qiang Liu, and Xunbin Wei, and Min Jin, and Changping Wu, and Qing Xie, and Yi Zhang, and Bing Wan, and Yanyun Zhang
January 2012, Immunological investigations,
Yi Zhang, and Wei Cai, and Qingrong Huang, and Yuting Gu, and Yufang Shi, and Jiefang Huang, and Fang Zhao, and Qiang Liu, and Xunbin Wei, and Min Jin, and Changping Wu, and Qing Xie, and Yi Zhang, and Bing Wan, and Yanyun Zhang
May 2023, Molecules (Basel, Switzerland),
Yi Zhang, and Wei Cai, and Qingrong Huang, and Yuting Gu, and Yufang Shi, and Jiefang Huang, and Fang Zhao, and Qiang Liu, and Xunbin Wei, and Min Jin, and Changping Wu, and Qing Xie, and Yi Zhang, and Bing Wan, and Yanyun Zhang
July 2009, Diabetologia,
Yi Zhang, and Wei Cai, and Qingrong Huang, and Yuting Gu, and Yufang Shi, and Jiefang Huang, and Fang Zhao, and Qiang Liu, and Xunbin Wei, and Min Jin, and Changping Wu, and Qing Xie, and Yi Zhang, and Bing Wan, and Yanyun Zhang
April 2015, Inflammation,
Yi Zhang, and Wei Cai, and Qingrong Huang, and Yuting Gu, and Yufang Shi, and Jiefang Huang, and Fang Zhao, and Qiang Liu, and Xunbin Wei, and Min Jin, and Changping Wu, and Qing Xie, and Yi Zhang, and Bing Wan, and Yanyun Zhang
January 2020, Frontiers in cell and developmental biology,
Yi Zhang, and Wei Cai, and Qingrong Huang, and Yuting Gu, and Yufang Shi, and Jiefang Huang, and Fang Zhao, and Qiang Liu, and Xunbin Wei, and Min Jin, and Changping Wu, and Qing Xie, and Yi Zhang, and Bing Wan, and Yanyun Zhang
May 2019, Stem cell research & therapy,
Yi Zhang, and Wei Cai, and Qingrong Huang, and Yuting Gu, and Yufang Shi, and Jiefang Huang, and Fang Zhao, and Qiang Liu, and Xunbin Wei, and Min Jin, and Changping Wu, and Qing Xie, and Yi Zhang, and Bing Wan, and Yanyun Zhang
June 2020, Journal of translational medicine,
Yi Zhang, and Wei Cai, and Qingrong Huang, and Yuting Gu, and Yufang Shi, and Jiefang Huang, and Fang Zhao, and Qiang Liu, and Xunbin Wei, and Min Jin, and Changping Wu, and Qing Xie, and Yi Zhang, and Bing Wan, and Yanyun Zhang
January 2020, Stem cell research & therapy,
Copied contents to your clipboard!